Trial NCT01605162

View at ClinicalTrials.gov 
Org. Study IDs: E7016-A001-201

Last trial update was posted on 2016-07-28

MeSH Interventions

10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one

MeSH Conditions

Melanoma

Other Conditions

Unresectable Stage III Melanoma Wild Type BRAF Stage IV Melanoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID